BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Vaccine News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Merck & Co.'s Fake MMR Trial Data Buried Even as Measles Outbreak Shows Vaccine Surge     1/27/2015
Asia's Biggest Vaccine Maker a Huge Threat to Drugmakers Like Merck & Co.     1/27/2015
Disneyland Measles Outbreak Casts Shadow on Anti-Vaccination Movement     1/21/2015
International Charity Slams GlaxoSmithKline, Pfizer for High Vaccine Prices     1/20/2015
Merck & Co. Jumps Into RNA Frenzy With $100 Million Bet on Moderna Therapeutics, Inc.     1/14/2015
GlaxoSmithKline's Experimental Shingles Vaccine Hits Goal In Late-Stage Study     12/19/2014
Bavarian Nordic Announces First Subject Dosed With Mva-Bn Filo In A Phase 1 Study Investigating A New Prime-Boost Regimen Of Ebola Candidate Vaccines     12/4/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Italy Declares Novartis AG FLUAD Vaccine Safe; Results Still Waiting On Agrippal Flu Vaccine     12/3/2014
Novartis AG Flu Vaccine FLUAD Suspended Following 13 Reported Deaths     12/3/2014
No Major Side Effects In Merck & Co., NewLink Genetics VSV-ZEBOV Ebola Vaccine Test     12/2/2014
GlaxoSmithKline, NIH Report Positive Ebola Vaccine Phase 1 Trial     12/1/2014
Dynavax Technologies Corporation Regains Full Rights To Investigational TLR 7/9 Inhibitor DV1179 Following Expiration Of Collaboration With GlaxoSmithKline     12/1/2014
Drug Giant Merck & Co. Buys Rights To NewLink Genetics Ebola Vaccine rVSV-EBOV     11/24/2014
GlaxoSmithKline Shareholders To Vote On Novartis AG Deal On Dec. 18     11/24/2014
 Featured Stories
Should Parents Not Vaccinating For Measles Be Sued?     1/29/2015
Anti-Vacciners Often Cluster In The Same Communities, Kaiser Permanente Reveals     1/19/2015
Nearly Half Of Americans Think The Flu Shot Can Make You Sick     12/10/2014
Ebola Vaccine Running Into Patent Cover In Canada?     11/21/2014
Do-It-Yourself Flu Vaccine? Study Shows It Works, U.S. Military Vaccine Agency Reveals     10/9/2014
Intestinal Bacteria May Boost Flu Shot's Effects, Emory University Study     9/18/2014
Robert Kennedy's Dangerous Anti-Vaccine Activism     7/22/2014
A Vaccination To Prevent Heart Attacks? Harvard Stem Cell Institute Study     6/11/2014
Vaccine Combo Doubles Seizure Risk In Babies, University of Calgary Study     6/10/2014
Zero Link Between Autism And Vaccines, Vaccine Reveals     5/20/2014
Body Odor Changes Following Vaccination, Monell Chemical Senses Center And United States Department Of Agriculture (USDA) Study     4/3/2014
Proteins May Pave Way to Cow Vaccine, University of Florida Study     7/19/2011
Discovery of Natural Antibody Brings a Universal Flu Vaccine a Step Closer, The Scripps Research Institute Study     7/11/2011
Leeds University Scientists Develop New Approach For Cancer Vaccine     6/21/2011
Drugmakers Including Novartis AG Gear Up to Copy Biotech Drugs in U.S.     5/12/2011
 More News
Clinical Efficacy Study Of Flublok® Quadrivalent Compares Flublok To A Traditional Egg-Based Flu Vaccine     1/29/2015
Soligenix (SNGX) Announces Publication Successfully Demonstrating Enhanced Immunogenicity Of Its Heat-Stable Anthrax Vaccine     1/29/2015
Bill & Melinda Gates Foundation, UK Take Lead In $7.5 Billion Pledge For Children's Vaccines     1/28/2015
Phibro Animal Health Corporation Announces Licensing Agreement With Merial For Phibro's Vaccine Delivery Technology     1/27/2015
The National Meningitis Association (NMA) Applauds FDA Approval Of Second Vaccine To Protect Against Serogroup B Meningococcal Disease     1/26/2015
China Approves World's First Inactive Sabin Strain Polio Vaccine     1/20/2015
TapImmune Inc. (TPIV) Release: Positive Phase 1 Immune Responses In All Evaluable Ovarian And Breast Cancer Patients Advances Vaccine To Phase 2 Clinical Trials     1/12/2015
Soligenix (SNGX) Announces Publication of Combination Ricin/Anthrax Vaccine Data     12/29/2014
Pfenex Inc. (PFNX) Announces Active IND And Additional BARDA Funding For Recombinant Anthrax Vaccine Program, Px563L     12/22/2014
Pivotal Phase 3 Study Of GlaxoSmithKline (GSK) Shingles Candidate Vaccine Meets Its Primary Endpoint     12/18/2014
Sanofi Pasteur (SASY.PA) Announces FDA Approval Of Fluzone Intradermal Quadrivalent (Influenza Vaccine) For Adults     12/12/2014
Vical Incorporated (VICL) Completes Enrollment In Its Therapeutic HSV-2 Vaccine Clinical Trial     12/11/2014
Themis Bioscience’s Vaccine Against Chikungunya Successful In Phase 1     11/20/2014
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine     11/20/2014
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine     11/19/2014